Profile
KA Imaging has created color x-ray, which allows for early and more accurate diagnostics with higher radiology confidence. Healthcare economics shows a $3.5M cost saving/revenue generation for a hospital and we offer our product as both a capital purchase and subscription based. Our first product, Reveal, has received USA FDA 510(k) clearance, Health Canada and Australian (TGA) approvals. Our pipeline of sales is about $13M in the first 2 years with signed distribution contracts in USA, Canada, Australia, Taiwan, Indonesia, Malaysia, Pakistan and Mexico.

Website
www.kaimaging.comContact
-
Amol Karnick, Chief Executive OfficerEmail: akarnick@kaimaging.com
Event details
Date: September 13 - 15, 2021
Event contact
Patricia Cosgrove
Area Director
USA: Life Sciences
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca
Participants
6 in total
-
Artenga’s microbubble drug conjugates (MDC) and focused ultrasound (FUS) are key…
-
KA Imaging has created color x-ray, which allows for early and more accurate diagnostics with higher radiology…
-
Mediphage Bioceuticals, a preclinical-stage biotechnology company, is developing a next-generation non-viral gene…
-
Nanology Labs, a University of Toronto spin-off company, has developed a novel drug delivery platform technology…
-
Nucro-Technics is a full-service Contract Support Organization that specializes in the conduct of both GLP…
-
PocketMD is a 24/7 healthcare marketplace that connects patients with doctors and allied health professionals…